CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀÌÁ¦È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
  • Á÷ À§: ±³¼ö(÷´Ü¿¬±¸¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
32 ÇØ¿Ü Choi CH, Kang HS, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Int J Radiation Oncology Biol Phys 71(1):199-204, May 2008.  
31 ÇØ¿Ü Chae MH, Kim KS, Park SM, Jang IS, Seo TG, Kim DM, Kim IC, Lee JH, Park JS. IRF-2 regulates NF-kB activity by modulating the subcellular localization of NF-kB. Biochemical and Biophysical Research Communications 370(3):519-524, June 2008.  
30 ÇØ¿Ü Kang KH, Park SY, Rho SB, Lee JH. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis. Cardiovascular Research 79(1):150-160, July 2008.  
29 ÇØ¿Ü Choi CH, Song SY, Choi JJ, Park YA, Kang HS, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. BMC Cancer 8:295-301, October 2008.  
28 ÇØ¿Ü Lee EJ, Jo MW, Rho SB, Park KS, Yoo YN, Park JS, Chae MH, Zhang W, Lee JH. Dkk3, downregulated in cervical cancer, functions as a negative regulator of B-catenin. International Journal of Cancer 124(2):287-297, January 2009.  
27 ÇØ¿Ü Lee SJ, Kim WY, Lee JW, Kim HS, Choi YL, Ahn GH, Lee JH, Kim BG, Bae DS. Conization using electrosurgical conization and cold coagulation for international federation of gynecology and obstetrics stage IA1, squamous cell. International Journal of Gynecological Cancer 19(3):407-411, April 2009.  
26 ÇØ¿Ü Park KS, Choi KS, Kim HM, Kim KB, Lee MH, Lee JH, Kim JC, Rim CK. Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosis. Experimental and Molecular Medicine 41(6):371-380, June 2009.  
25 ÇØ¿Ü Lee YY, Kim TJ, Kim CJ, Kang HS, Choi CH, Lee JW, Kim BG, Lee JH, Bae DS. Single-port access laparoscopic-assisted vaginal hysterectomy: A novel method with a wound retractor and a glove. The Journal of Minimally Invasive Gynecology 16(4):450-453, July~August 2009.  
24 ÇØ¿Ü Lee YY, Choi CH, Kim CJ, Kang HS, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results. Gynecologic Oncology 115(1):65-68, October 2009.  
23 ÇØ¿Ü Kang HS, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG. Phase II study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian. Journal of Korean Medical Science 24(5):945-950, October 2009.  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729